<p>Methods and compositions for treating cancer comprising administering to a patient inhibitors of mT0RC1/C2, IGF-1 R, and IR. In some aspects, a combination of an mT0RC1/C2 inhibitor and an IGF-1 R/IR inhibitor is employed. Other aspects are described herein.</p>
申请公布号
WO2011112666(A1)
申请公布日期
2011.09.15
申请号
WO2011US27673
申请日期
2011.03.09
申请人
OSI PHARMACEUTICALS, LLC;BARR, SHARON;BUCK, ELIZABETH, A.;EPSTEIN, DAVID, M.;GOKHALE, PRAFULLA, C.;MIGLARESE, MARK, R.
发明人
BARR, SHARON;BUCK, ELIZABETH, A.;EPSTEIN, DAVID, M.;GOKHALE, PRAFULLA, C.;MIGLARESE, MARK, R.
